Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study

Diabetes is a lifelong course disease, so insulin treatment has to be effective and safe, and patients should be satisfied with it. We aimed to compare efficacy, safety, and quality of treatment satisfaction of human and premixed analogue insulin among 3264 patients (53.58% women) with type 2 diabet...

Full description

Saved in:
Bibliographic Details
Main Authors: Katarzyna Nabrdalik, Hanna Kwiendacz, Tomasz Sawczyn, Andrzej Tomasik, Michał Kukla, Małgorzata Masierek, Janusz Gumprecht
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2018/6536178
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849414616263688192
author Katarzyna Nabrdalik
Hanna Kwiendacz
Tomasz Sawczyn
Andrzej Tomasik
Michał Kukla
Małgorzata Masierek
Janusz Gumprecht
author_facet Katarzyna Nabrdalik
Hanna Kwiendacz
Tomasz Sawczyn
Andrzej Tomasik
Michał Kukla
Małgorzata Masierek
Janusz Gumprecht
author_sort Katarzyna Nabrdalik
collection DOAJ
description Diabetes is a lifelong course disease, so insulin treatment has to be effective and safe, and patients should be satisfied with it. We aimed to compare efficacy, safety, and quality of treatment satisfaction of human and premixed analogue insulin among 3264 patients (53.58% women) with type 2 diabetes mellitus (T2DM) in a real-life environment. 2493 patients (62.77%) had been assigned to group I where before the inclusion into the study the treatment regimen has been changed from analogue to human premixed insulin and 771 patients (37.23%) to group II where the treatment with insulin analogue remained unchanged. At the end of the study, there was a reduction of HbA1c observed in both of the groups; however, Δ HbA1c was significantly higher in group 1 (−0.599 versus −0.406; P<0.001 at visit 3 versus visit 1). The number of hypoglycemic episodes during the study observation was insignificantly reduced in both groups. Diabetes treatment satisfaction measured with DTSQ increased at the end of the study and was significantly better in group I compared to group II (P<0.001). This observational study proved that both human and premixed analogue insulin are effective and safe, and patients are satisfied with the treatment.
format Article
id doaj-art-6b916a2a89a94087806925e9d9c812c8
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-6b916a2a89a94087806925e9d9c812c82025-08-20T03:33:46ZengWileyInternational Journal of Endocrinology1687-83371687-83452018-01-01201810.1155/2018/65361786536178Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational StudyKatarzyna Nabrdalik0Hanna Kwiendacz1Tomasz Sawczyn2Andrzej Tomasik3Michał Kukla4Małgorzata Masierek5Janusz Gumprecht6Department of Internal Medicine, Diabetology and Nephrology in Zabrze, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, PolandDepartment of Internal Medicine, Diabetology and Nephrology in Zabrze, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, PolandDepartment of Physiology in Zabrze, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, PolandSecond Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, PolandDepartment of Gastroenterology and Hepatology in Katowice, Medical University of Silesia, Katowice, PolandBIOTON S.A., Warsaw, PolandDepartment of Internal Medicine, Diabetology and Nephrology in Zabrze, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, PolandDiabetes is a lifelong course disease, so insulin treatment has to be effective and safe, and patients should be satisfied with it. We aimed to compare efficacy, safety, and quality of treatment satisfaction of human and premixed analogue insulin among 3264 patients (53.58% women) with type 2 diabetes mellitus (T2DM) in a real-life environment. 2493 patients (62.77%) had been assigned to group I where before the inclusion into the study the treatment regimen has been changed from analogue to human premixed insulin and 771 patients (37.23%) to group II where the treatment with insulin analogue remained unchanged. At the end of the study, there was a reduction of HbA1c observed in both of the groups; however, Δ HbA1c was significantly higher in group 1 (−0.599 versus −0.406; P<0.001 at visit 3 versus visit 1). The number of hypoglycemic episodes during the study observation was insignificantly reduced in both groups. Diabetes treatment satisfaction measured with DTSQ increased at the end of the study and was significantly better in group I compared to group II (P<0.001). This observational study proved that both human and premixed analogue insulin are effective and safe, and patients are satisfied with the treatment.http://dx.doi.org/10.1155/2018/6536178
spellingShingle Katarzyna Nabrdalik
Hanna Kwiendacz
Tomasz Sawczyn
Andrzej Tomasik
Michał Kukla
Małgorzata Masierek
Janusz Gumprecht
Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
International Journal of Endocrinology
title Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
title_full Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
title_fullStr Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
title_full_unstemmed Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
title_short Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
title_sort efficacy safety and quality of treatment satisfaction of premixed human and analogue insulin regimens in a large cohort of type 2 diabetic patients progens benefit observational study
url http://dx.doi.org/10.1155/2018/6536178
work_keys_str_mv AT katarzynanabrdalik efficacysafetyandqualityoftreatmentsatisfactionofpremixedhumanandanalogueinsulinregimensinalargecohortoftype2diabeticpatientsprogensbenefitobservationalstudy
AT hannakwiendacz efficacysafetyandqualityoftreatmentsatisfactionofpremixedhumanandanalogueinsulinregimensinalargecohortoftype2diabeticpatientsprogensbenefitobservationalstudy
AT tomaszsawczyn efficacysafetyandqualityoftreatmentsatisfactionofpremixedhumanandanalogueinsulinregimensinalargecohortoftype2diabeticpatientsprogensbenefitobservationalstudy
AT andrzejtomasik efficacysafetyandqualityoftreatmentsatisfactionofpremixedhumanandanalogueinsulinregimensinalargecohortoftype2diabeticpatientsprogensbenefitobservationalstudy
AT michałkukla efficacysafetyandqualityoftreatmentsatisfactionofpremixedhumanandanalogueinsulinregimensinalargecohortoftype2diabeticpatientsprogensbenefitobservationalstudy
AT małgorzatamasierek efficacysafetyandqualityoftreatmentsatisfactionofpremixedhumanandanalogueinsulinregimensinalargecohortoftype2diabeticpatientsprogensbenefitobservationalstudy
AT januszgumprecht efficacysafetyandqualityoftreatmentsatisfactionofpremixedhumanandanalogueinsulinregimensinalargecohortoftype2diabeticpatientsprogensbenefitobservationalstudy